Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × Watchful Waiting × Clear all

NCT06861894 2025-05-15

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma